✦ LIBER ✦
6091 POSTER Final Results of a Multicentre Phase II Trial Assessing Sorafenib in Combination With Irinotecan as 2nd or Later-line Treatment in Metastatic Colorectal Cancer (mCRC) Patients With KRas Mutated Tumours (mt) (NEXIRI)
✍ Scribed by Samalin, E.; Bouche, O.; Thezenas, S.; Frangois, E.; Adenis, A.; Bennouna, J.; Taieb, J.; Desseigne, F.; Laurent-Puig, P.; Ychou, M.
- Book ID
- 123151725
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 44 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.